These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 6914464)
21. Entitlement to Medicare benefits based on end-stage renal disease: final regulation. Fed Regist; 1978 Sep; 43(189):44801-4. PubMed ID: 10297231 [No Abstract] [Full Text] [Related]
22. Court invalidates parts of Medicare ESRD payment plan. Peterson RN; Pristave RJ Health Law Vigil; 1984 Sep; 7(19):7-12. PubMed ID: 10299657 [No Abstract] [Full Text] [Related]
23. Surviving change: Can the ESRD provisions in the SCHIP create a level playing field? Gardner AV Nephrol News Issues; 2007 Sep; 21(10):52-3. PubMed ID: 17918480 [No Abstract] [Full Text] [Related]
24. The politics of health cost containment: end-stage renal disease. Rettig RA Bull N Y Acad Med; 1980; 56(1):115-38. PubMed ID: 6986928 [No Abstract] [Full Text] [Related]
25. KI study: older patients with CKD are costly as they transition to dialysis. St Peter W Nephrol News Issues; 2004 Oct; 18(11):85. PubMed ID: 15551617 [No Abstract] [Full Text] [Related]
26. NMC, ProPAC discuss alternative methods for EPO reimbursement. Neumann ME Nephrol News Issues; 1994 Jun; 8(6):8, 10-1. PubMed ID: 8008097 [No Abstract] [Full Text] [Related]
27. ESRD program at the crossroads of health care reform. Neumann ME Nephrol News Issues; 1993 Oct; 7(10):5, 40. PubMed ID: 8232632 [No Abstract] [Full Text] [Related]
28. Who should be paying for vitamin D analogues--Medicare or the patients? Hall G Nephrol Nurs J; 2006; 33(3):345-6, 351. PubMed ID: 16859205 [No Abstract] [Full Text] [Related]
29. End-stage renal disease and chronic kidney disease in Brazil. Lugon JR Ethn Dis; 2009; 19(1 Suppl 1):S1-7-9. PubMed ID: 19484865 [TBL] [Abstract][Full Text] [Related]
30. Can we revitalize the ESRD program? McFeeley T Nephrol News Issues; 2004 Apr; 18(5):42-3, 47, 87. PubMed ID: 15125164 [No Abstract] [Full Text] [Related]
31. Cost functions for dialysis facilities and the quality of dialysis. Escarce JJ; Feldman HI Health Serv Res; 1999 Feb; 33(6):1563-6. PubMed ID: 10029497 [No Abstract] [Full Text] [Related]
32. Technology: tools or toys, is it economically feasible with current reimbursement? The case in favor. Tattersall J Blood Purif; 2001; 19(2):185-8. PubMed ID: 11150807 [No Abstract] [Full Text] [Related]
33. Conditions for coverage fail to relieve administrative burden. Wish D Nephrol News Issues; 2005 Sep; 19(10):46-7, 51. PubMed ID: 16187648 [No Abstract] [Full Text] [Related]